Yahoo
Taiwan - Delayed Quote TWD

Polaris Group (6550.TW)

15.05 +0.30 (+2.03%)
At close: 1:30:19 PM GMT+8
Chart Range Bar
Loading chart for 6550.TW
  • Previous Close 14.75
  • Open 14.60
  • Bid 15.05 x --
  • Ask 15.10 x --
  • Day's Range 14.60 - 15.25
  • 52 Week Range 14.60 - 69.20
  • Volume 276,755
  • Avg. Volume 585,114
  • Market Cap (intraday) 6.996B
  • Beta (5Y Monthly) 0.70
  • PE Ratio (TTM) --
  • EPS (TTM) -9.05
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Polaris Group, together with its subsidiaries, offers biotechnology, pharmaceutical testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It also offers healthcare consulting, staffing, and MDS solutions. The company was incorporated in 2006 and is based in Grand Cayman, Cayman Islands.

www.polaris-group.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is TSEC CAPITALIZATION WEIGHTED ST (^TWII) .

YTD Return

6550.TW
74.86%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
55.09%

1-Year Return

6550.TW
77.21%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
59.10%

3-Year Return

6550.TW
89.19%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
173.95%

5-Year Return

6550.TW
88.98%
TSEC CAPITALIZATION WEIGHTED ST (^TWII)
163.21%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY22
Revenue 349k
Earnings --
Profit Margin 0.00%

Q2

FY22

Q3

FY22

0
500K
1M
2M
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -20.42%

  • Return on Equity (ttm)

    -81.10%

  • Revenue (ttm)

    67.95M

  • Net Income Avi to Common (ttm)

    -3.77B

  • Diluted EPS (ttm)

    -9.05

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.35B

  • Total Debt/Equity (mrq)

    52.06%

  • Levered Free Cash Flow (ttm)

    -1.17B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: